SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

被引：0
|
作者：
Velthuis, K. [1 ]
Nguyen, M. [1 ]
Scholl, J. [1 ]
Jansen, J. [1 ]
Van Lint, J. [1 ]
Ten Klooster, P. [2 ,3 ]
Vonkeman, H. [3 ,4 ]
Jessurun, N. [1 ]
机构：
[1] Netherlands Pharmacovigilance Ctr Lareb, Res Dept, sHertogenbosch, Netherlands
[2] Transparency Healthcare BV, Hengelo, Netherlands
[3] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands
[4] Medisch Spectrum Twente, Dept Rheumatol & Clin Immunol, Enschede, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0648
引用
收藏
页码：562 / 563
页数：2
相关论文
共 50 条
  • [31] Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug
    Rich, E
    Moreland, LW
    Alarcón, GS
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (02) : 259 - 261
  • [32] Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
    Wilke, Thomas
    Mueller, Sabrina
    Lee, Sze Chim
    Majer, Istvan
    Heisen, Marieke
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [33] Impact of Obesity on Drug Survival of Tofacitinib in Patients with Rheumatoid Arthritis: Analysis from the Turkbio Registry
    Babaoglu, Hakan
    Goker, Borna
    Inanc, Nevsun
    Birlik, Merih
    Koca, Suleyman Serdar
    Cefle, Ayse
    Dalkilic, Ediz
    Tufan, Abdurrahman
    Yilmaz, Sema
    Senel, Soner
    Akar, Servet
    Akkoc, Nurullah
    Onen, Fatos
    Gazel, Ummugulsum
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [34] Comparison of efficacy and tolerability of triple combination therapy (methotrexate plus sulfasalazine plus hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
    Gubar, E. E.
    Bochkova, A. G.
    Bunchuk, N., V
    TERAPEVTICHESKII ARKHIV, 2008, 80 (05): : 25 - 30
  • [35] THE EFFECTS OF MTHFR GENE VARIATIONS ON DRUG RESPONSE IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS TREATED WITH METHOTREXATE
    Horelli-Kuitunen, N.
    Kaistamaa, M.
    Onkamo, P.
    Nenonen, A.
    Ahola, L.
    Ihalainen, J.
    Laiho, K.
    Kauppi, M.
    Nystrom, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) : 405 - 405
  • [36] DRUG SURVIVAL AND THE ASSOCIATED PREDICTORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TACROLIMUS
    Park, E. K.
    Lee, S. G.
    Koo, D. W.
    Kim, G. T.
    Lee, J. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 978 - 979
  • [37] Drug survival on tumour necrosis factor inhibitors in patients with rheumatoid arthritis in Finland
    Aaltonen, K. J.
    Joensuu, J. T.
    Pirila, L.
    Kauppi, M.
    Uutela, T.
    Varjolahti-Lehtinen, T.
    Yli-Kerttula, T.
    Isomaki, P.
    Nordstrom, D.
    Sokka, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 359 - 363
  • [38] Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Emery, Paul
    Vlahos, Bonnie
    Szczypa, Piotr
    Thakur, Mazhar
    Jones, Heather E.
    Woolcott, John
    Estrella, Paul V. Santos
    Rolland, Catherine
    Gibofsky, Allan
    Citera, Gustavo
    Sockalingam, Sargunan
    Marshall, Lisa
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 493 - 501
  • [39] Drug survival of leflunomide for treatment of patients with rheumatoid arthritis in daily clinical practice
    Kievit, W
    Welsing, PMJ
    Franssen, J
    van Riel, PLCM
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [40] Low Persistence Rates in Patients With Rheumatoid Arthritis Treated With Triple Therapy and Adverse Drug Events Associated With Sulfasalazine
    Erhardt, Daniel P.
    Cannon, Grant W.
    Teng, Chia-Chen
    Mikuls, Ted R.
    Curtis, Jeffrey R.
    Sauer, Brian C.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (10) : 1326 - 1335
12345